Get App
Indian pharma companies are expected to continue their growth momentum and profitability in US, helped by new product launches, ongoing drug shortages and growth opportunities in the domestic formulation business, according to rating agency India Ratings and Research (Ind-Ra). The ...
The domestic active pharmaceutical ingredient (API) industry is expected to grow at a CAGR of about 7%-8% over the next three to four years, according to ICRA rating agency. The estimated size of the industry is about Rs. 1,000-1,100 billion ...